Monkeypox vaccination involves using vaccines to reduce the risk and severity of mpox infection. Two vaccines are available in the United States for this purpose.
Available Monkeypox Vaccines
Currently, two vaccines are used to combat monkeypox:
- JYNNEOS® (also known as Imvamune or Imvanex): This is the preferred vaccine for the current mpox outbreak. While supply is increasing, availability may still be limited in some areas.
- ACAM2000: This is another vaccine option.
Key Points About Monkeypox Vaccination
Here are some important considerations about mpox vaccination:
- Primary Goal: The main objective is to lessen the chances of contracting mpox and reduce the severity of symptoms if infection occurs.
- JYNNEOS® Preference: JYNNEOS® is the more favored vaccine during the present mpox outbreak due to its safety profile.
- Vaccine Supply: Although the supply of JYNNEOS® is improving, its availability might be restricted depending on the location.
| Vaccine | Preferred for Current Outbreak | Supply Availability |
|---|---|---|
| JYNNEOS® | Yes | Increasing, may be limited |
| ACAM2000 | No | Available |
Practical Insights
- If you are at risk of mpox, consult with your healthcare provider to determine the most appropriate vaccination strategy.
- Stay informed about the current recommendations and availability of vaccines in your area.
- Seek vaccination as a vital tool in protecting yourself and your community from mpox.
